Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine and Dexmedetomidine for PCA After Scoliosis Surgery
NCT04791059Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Apr 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine and dexmedetomidine in postoperative pain (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Percent of patients with moderate to severe pain within 72 hours. Started Apr 2021; status: completed.
02
Drugs
esketaminedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04791059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04791059.